...
首页> 外文期刊>Journal of proteome research >Metabolomic Profiling of the Synergistic Effects of Ginsenoside Rg1 in Combination with Neural Stem Cell Transplantation in Ischemic Stroke Rats
【24h】

Metabolomic Profiling of the Synergistic Effects of Ginsenoside Rg1 in Combination with Neural Stem Cell Transplantation in Ischemic Stroke Rats

机译:人参皂苷RG1与神经干细胞移植组合在缺血性卒中大鼠中的协同作用的代谢物分析

获取原文
获取原文并翻译 | 示例
           

摘要

As the greatest medical and socioeconomic problem in developing countries, stroke is the second or third leading cause of death in China and worldwide. In adult organisms suffering from stroke, transplanted stem cells have the ability to repair damaged tissues by regenerating autologous cells, while ginsenoside Rg1 could promote proliferation and differentiation of stem cells. Although obvious antistroke effects of ginsenoside Rg1 and transplanted stem cells have been verified in publications, the mechanism exploration remains challenging. Our study was carried out to investigate the synergistic effects of ginsenoside Rg1 and neural stem cell (NSC) transplantation on MCAO rats with a H-1 NMR-based nontargeted metabolomics method to identify potential biomarkers and protein targets and discover the potential mechanism. NSCs transplantation after MCAO combined with ginsenoside Rg1 administration could significantly improve the cerebral infarct and neurological deficits. The treatment significantly intervened the levels of ten metabolites, and perturbed energy metabolism, amino acids metabolism, and lipids metabolism. And 11 enzymes were identified and verified as the targets of NSCs transplantation and ginsenoside Rg1 administration on MCAO rats. Our findings helped to improve the antistroke mechanism of NSCs transplantation and ginsenoside Rg1 and supply a theory basis for the combined research of stem cells and Chinese medicine in the future.
机译:作为发展中国家最大的医疗和社会经济问题,中风是中国和全球的第二个或第三个导致死亡原因。在患有中风的成人生物中,移植的干细胞具有通过再生自体细胞来修复受损组织的能力,而人参皂苷RG1可以促进干细胞的增殖和分化。虽然在出版物中已经核实了人参皂甙RG1和移植干细胞的明显抗钻性能,但机制勘探仍然具有挑战性。我们的研究是为了探讨人参皂苷RG1和神经干细胞(NSC)移植对MCAO大鼠的协同作用,以H-1 NMR的不靶向代谢组学方法鉴定潜在的生物标志物和蛋白质靶点并发现潜在机制。 MCAO与人参皂甙RG1施用后的NSCs移植可以显着改善脑梗死和神经缺陷。治疗明显干预了十代谢物的水平,扰动能量代谢,氨基酸代谢和脂质代谢。鉴定出11个酶并验证为MCAO大鼠NSCs移植和人参皂苷RG1给药的靶。我们的研究结果有助于改善NSCs移植和人参皂甙RG1的Antistroke机制,并为未来的干细胞和中药的组合研究提供理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号